BioLargo posts Sept. 10 investor presentation
BioLargo, Inc. (BLGO) furnished an investor slide presentation in connection with a webcast investor conference held on September 10, 2026 at 1:00 PM Pacific Time.
Rhea-AI Filing Summary
BioLargo, Inc. (BLGO) furnished an investor slide presentation in connection with a webcast investor conference held on September 10, 2026 at 1:00 PM Pacific Time. The slides are provided as Exhibit 99.1 under a Regulation FD disclosure and are expressly treated as “furnished,” not “filed,” under federal securities laws.
The company states that the information in this report and its exhibits will not be incorporated by reference into other SEC filings and that it undertakes no obligation to update the disclosed information, directing readers to the “Safe Harbor Act” discussion in the exhibit for important forward-looking statement information.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 7.01, 9.01
2 items
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Webcast presentation date: September 10, 2026
Webcast presentation time: 1:00 PM Pacific Time
Exhibit 99.1: Slide deck presentation
+1 more
4 metrics
Webcast presentation date
September 10, 2026
Date of the investor webcast where the slide deck was presented
Webcast presentation time
1:00 PM Pacific Time
Time of the investor webcast presentation
Exhibit 99.1
Slide deck presentation
Furnished under Item 7.01 Regulation FD Disclosure
Exhibit 104
Cover Page Interactive Data File
Embedded within the Inline XBRL document
Key Terms
Regulation FD, forward looking statements, Safe Harbor Act, Inline XBRL
4 terms
Regulation FD regulatory
"Item 7.01 Regulation FD Disclosure. BioLargo, Inc. presented the slides"
Regulation FD is a rule that prevents company insiders, like executives, from sharing important information with some people before others get it. It matters because it helps ensure all investors have equal access to key news, making the stock market fairer and reducing chances of insider trading.
forward looking statements regulatory
"For important information about forward looking statements, see the information"
Statements about a company’s expected future performance, plans, goals, or projections that are not historical facts and involve assumptions and estimates. Investors care because these are predictions that guide decisions but can be wrong; like a weather forecast, they help set expectations and risk — if circumstances change, actual results may differ significantly, so investors should weigh them alongside hard data and risk factors.
Safe Harbor Act regulatory
"see the information under the heading “Safe Harbor Act” in the exhibits"
Inline XBRL technical
"Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did BioLargo, Inc. (BLGO) announce in this 8-K?
BioLargo, Inc. furnished an investor slide presentation as Exhibit 99.1 related to a webcast investor conference on September 10, 2026. The material is provided under a Regulation FD disclosure and is not deemed filed for liability purposes.
When did BLGO present the investor slides mentioned in the 8-K?
The investor slides were presented on September 10, 2026, at 1:00 PM Pacific Time during a webcast investor conference. The same slide deck is attached as Exhibit 99.1 for investors to review.
Are the BLGO investor slides considered filed with the SEC?
No. BioLargo states that the information in Item 7.01 and Exhibit 99.1 is furnished, not filed, and therefore is not subject to Section 18 of the Exchange Act or Sections 11 and 12(a)(2) of the Securities Act.
Will BioLargo (BLGO) update the information in this investor presentation?
BioLargo states it undertakes no duty or obligation to update or revise the information in the report or exhibits, although management may do so through future SEC reports, press releases, or other public disclosures.
What exhibits are included with BioLargo’s (BLGO) 8-K?
The 8-K lists two exhibits: Exhibit 99.1, described as a slide deck presentation, and Exhibit 104, the Cover Page Interactive Data File embedded within the Inline XBRL document.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 10, 2026
|
|
|
(Exact name of registrant as specified in its charter)
|
|
|
|
|
||
|
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant’s telephone number, including area code: (888 ) 400-2863
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
OTCQX
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure.
BioLargo, Inc. presented the slides attached as Exhibit 99.1, which are incorporated herein by reference, on September 10, 2026, at 1:00 PM Pacific Time, at a webcast investor conference.
The information in this Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 7.01 and in the exhibits to this Current Report shall not be incorporated by reference into any filing with the SEC made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. The Company undertakes no duty or obligation to update or revise the information contained in this report, although it may do so from time to time as its management believes is appropriate. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosures. For important information about forward looking statements, see the information under the heading “Safe Harbor Act” in the exhibits attached hereto.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit No.
|
Description
|
|
99.1
|
Slide deck presentation
|
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: September 11, 2026
|
BIOLARGO, INC.
|
|||||||
|
By:
|
/s/ Dennis P. Calvert
|
|||||||
|
Dennis P. Calvert
|
||||||||
|
President and Chief Executive Officer
|
||||||||
Exhibit 99.1
